Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery

Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparision of immunocytochemical tumor cells staining and RT-PCR

Mapara, M.Y.
Koerner, I.J.
Hildebrandt, M.
Bargou, R.C.
Krahl, D.
Reichardt, P.
Doerken, B.

January 1997

We studied the efficiency of indirect tumor cell purging via enrichment of CD34+ hematopoietic proge...

Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma.

Van Riet, Ivan
Schots, Rik
Balduc, N.
Van den Brande, G.
Sariban, Eric
Otten, Jacques
Van Camp, Ben

January 1990

Bone marrow grafts of 5 patients with stage IV neuroblastoma and one patient with stage IV retinobla...

Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-11

Carolien P. Schröder
Bart-jan Kroesen
Elisabeth G. E. De Vries

January 2015

Peripheral blood stem cell (PBSC) support in breast cancer patients allows high-dose chemotherapy, b...

Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery

Pedrazzoli, P
Lanza, A
Battaglia, M
Da Prada, G A
Zambelli, A
Perotti, C
Ponchio, L
Salvaneschi, L
Robustelli della Cuna, G

January 2000

Because tumor contamination of hematopoietic stem cell grafts may influence the outcome in breast ca...

Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer

Hohaus, S
Pförsich, M
Murea, S
Abdallah, A
Lin, Ys
Funk, L
Kaul, S
Schmid, H
Wallwiener, D
Haas, R.
VOSO, MARIA TERESA

June 1997

Contamination of transplants with tumour cells may contribute to relapse after peripheral blood stem...

Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions

C. Tarella
P. Corradini
M. Astolfi
P. Bondesan
D. Caracciolo
C. Cherasco
M. Ladetto
F. Giaretta
I. Ricca
U. Vitolo
A. Pileri
D. Ferrero

September 1999

The feasibility and efficacy of a novel immunomagnetic ex vivo negative purging method was evaluated...

Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests

Davies, F. E.
Rawstron, A. C.
Pratt, G.
Coupe, R.
Clarke, D.
Lubenko, A.
Short, K.
Perren, T. J.
Selby, P. J.
Maclennan, S.
Major, K.
Woodhead, V.
Robinson, F.
Child, J. A.
Smith, G. M.
Johnson, Peter W.M.
Morgan, G. J.

September 2000

Peripheral blood progenitor cells used during high dose treatments for malignancy may be contaminate...

Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: Predictors and clinical relevance

Pecora, Andrew L
Lazarus, Hillard M
Jennis, Andrew A
Preti, Robert A
Goldberg, Stuart L
Rowley, Scott D
Cantwell, Susan
Cooper, Brenda W
Copelan, Edward A
Herzig, Roger H
Meagher, Richard
Kennedy, M.John
Akard, Luke P
Jansen, Jan
Ross, Amy
Prilutskaya, Marina
Glassco, John
Kahn, Douglas
Moss, Thomas J

October 2002

AbstractThe incidence and clinical relevance of tumor cells contaminating the stem cell products of ...

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

Jacquy, Caroline
Lambert, Frédéric
Soree, Anne
Van Daele, S
Heusterspreute, M
Bosly, André
Ferrant, Augustin
Parma, Jasmine
Bron, Dominique
Martiat, Philippe

April 1999

Intensification using peripheral blood stem cells collected after chemotherapy followed by growth fa...

Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device – a local experience

Cf Leong Frcpa
Habsah A Bsc
Hs Teh Mmed
Ky Goh Mrcp
Saw Fadilah Mmed
Cheong Frcpa

March 2015

Introduction: Peripheral blood stem cells (PBSC) mobilised with growth factor with or without chemot...

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma

Webb, Iain J
Friedberg, Jonathan W
Gribben, John G
Fisher, David C
Spitzer, Thomas
Neuberg, Donna
Jallow, Haddy
Kim, Helen
Houde, Heather
Monroy, Ron
Schmittling, Robert
Freedman, Arnold S

August 2002

AbstractContamination of hematopoietic stem cells (HSCs) with tumor cells has been associated with i...

Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting

DiPersio, John F.
Ho, Anthony D.
Hanrahan, Jessie
Hsu, Frank J.
Fruehauf, Stefan

July 2011

Autologous transplantation of peripheral blood (PB) hematopoietic stem cells (HSCs) is a widely used...

Bispecific antibodies effectively purge cancer cells from peripheral blood stem cell collections without affecting colony forming units.

Lindhofer, H.
Menzel, H.
Zenaerle, U.
Zeidler, R.

January 1997

Peripheral blood stem cell collections (PBSC) are increasingly being used for hematopoietic reconsti...

Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1

Schroder, CP
Kroesen, BJ
de Leij, LFMH
de Vries, EGE

June 2000

Peripheral blood stem cell (PBSC) support in breast cancer patients allows high-dose chemotherapy, b...

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

Liu, Z.
Fusi, A.
Klopocki, E.
Schmittel, A.
Tinhofer, I.
Nonnenmacher, A.
Keilholz, U.

January 2011

BACKGROUND: A limitation of positive selection strategies to enrich for circulating tumor cells (CTC...

Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparision of immunocytochemical tumor cells staining and RT-PCR

Mapara, M.Y.
Koerner, I.J.
Hildebrandt, M.
Bargou, R.C.
Krahl, D.
Reichardt, P.
Doerken, B.

January 1997

We studied the efficiency of indirect tumor cell purging via enrichment of CD34+ hematopoietic proge...

Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma.

Van Riet, Ivan
Schots, Rik
Balduc, N.
Van den Brande, G.
Sariban, Eric
Otten, Jacques
Van Camp, Ben

January 1990

Bone marrow grafts of 5 patients with stage IV neuroblastoma and one patient with stage IV retinobla...

Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-11

Carolien P. Schröder
Bart-jan Kroesen
Elisabeth G. E. De Vries

January 2015

Peripheral blood stem cell (PBSC) support in breast cancer patients allows high-dose chemotherapy, b...

Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery

Pedrazzoli, P
Lanza, A
Battaglia, M
Da Prada, G A
Zambelli, A
Perotti, C
Ponchio, L
Salvaneschi, L
Robustelli della Cuna, G

January 2000

Because tumor contamination of hematopoietic stem cell grafts may influence the outcome in breast ca...

Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer

Hohaus, S
Pförsich, M
Murea, S
Abdallah, A
Lin, Ys
Funk, L
Kaul, S
Schmid, H
Wallwiener, D
Haas, R.
VOSO, MARIA TERESA

June 1997

Contamination of transplants with tumour cells may contribute to relapse after peripheral blood stem...

Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions

C. Tarella
P. Corradini
M. Astolfi
P. Bondesan
D. Caracciolo
C. Cherasco
M. Ladetto
F. Giaretta
I. Ricca
U. Vitolo
A. Pileri
D. Ferrero

September 1999

The feasibility and efficacy of a novel immunomagnetic ex vivo negative purging method was evaluated...

Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests

Davies, F. E.
Rawstron, A. C.
Pratt, G.
Coupe, R.
Clarke, D.
Lubenko, A.
Short, K.
Perren, T. J.
Selby, P. J.
Maclennan, S.
Major, K.
Woodhead, V.
Robinson, F.
Child, J. A.
Smith, G. M.
Johnson, Peter W.M.
Morgan, G. J.

September 2000

Peripheral blood progenitor cells used during high dose treatments for malignancy may be contaminate...

Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: Predictors and clinical relevance

Pecora, Andrew L
Lazarus, Hillard M
Jennis, Andrew A
Preti, Robert A
Goldberg, Stuart L
Rowley, Scott D
Cantwell, Susan
Cooper, Brenda W
Copelan, Edward A
Herzig, Roger H
Meagher, Richard
Kennedy, M.John
Akard, Luke P
Jansen, Jan
Ross, Amy
Prilutskaya, Marina
Glassco, John
Kahn, Douglas
Moss, Thomas J

October 2002

AbstractThe incidence and clinical relevance of tumor cells contaminating the stem cell products of ...

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

Jacquy, Caroline
Lambert, Frédéric
Soree, Anne
Van Daele, S
Heusterspreute, M
Bosly, André
Ferrant, Augustin
Parma, Jasmine
Bron, Dominique
Martiat, Philippe

April 1999

Intensification using peripheral blood stem cells collected after chemotherapy followed by growth fa...

Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device – a local experience

Cf Leong Frcpa
Habsah A Bsc
Hs Teh Mmed
Ky Goh Mrcp
Saw Fadilah Mmed
Cheong Frcpa

March 2015

Introduction: Peripheral blood stem cells (PBSC) mobilised with growth factor with or without chemot...

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma

Webb, Iain J
Friedberg, Jonathan W
Gribben, John G
Fisher, David C
Spitzer, Thomas
Neuberg, Donna
Jallow, Haddy
Kim, Helen
Houde, Heather
Monroy, Ron
Schmittling, Robert
Freedman, Arnold S

August 2002

AbstractContamination of hematopoietic stem cells (HSCs) with tumor cells has been associated with i...

Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting

DiPersio, John F.
Ho, Anthony D.
Hanrahan, Jessie
Hsu, Frank J.
Fruehauf, Stefan

July 2011

Autologous transplantation of peripheral blood (PB) hematopoietic stem cells (HSCs) is a widely used...

Bispecific antibodies effectively purge cancer cells from peripheral blood stem cell collections without affecting colony forming units.

Lindhofer, H.
Menzel, H.
Zenaerle, U.
Zeidler, R.

January 1997

Peripheral blood stem cell collections (PBSC) are increasingly being used for hematopoietic reconsti...

Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1

Schroder, CP
Kroesen, BJ
de Leij, LFMH
de Vries, EGE

June 2000

Peripheral blood stem cell (PBSC) support in breast cancer patients allows high-dose chemotherapy, b...

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

Liu, Z.
Fusi, A.
Klopocki, E.
Schmittel, A.
Tinhofer, I.
Nonnenmacher, A.
Keilholz, U.

January 2011

BACKGROUND: A limitation of positive selection strategies to enrich for circulating tumor cells (CTC...

Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparision of immunocytochemical tumor cells staining and RT-PCR

Mapara, M.Y.
Koerner, I.J.
Hildebrandt, M.
Bargou, R.C.
Krahl, D.
Reichardt, P.
Doerken, B.

January 1997

We studied the efficiency of indirect tumor cell purging via enrichment of CD34+ hematopoietic proge...

Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma.

Van Riet, Ivan
Schots, Rik
Balduc, N.
Van den Brande, G.
Sariban, Eric
Otten, Jacques
Van Camp, Ben

January 1990

Bone marrow grafts of 5 patients with stage IV neuroblastoma and one patient with stage IV retinobla...

Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-11

Carolien P. Schröder
Bart-jan Kroesen
Elisabeth G. E. De Vries

January 2015

Peripheral blood stem cell (PBSC) support in breast cancer patients allows high-dose chemotherapy, b...

Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery

Abstract

Extracted data

Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery

Abstract

Extracted data

Related items

Related items